Clinical usefulness of post-treatment FDG PET/CT in patients with ovarian malignancy
- 14 June 2016
- journal article
- research article
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 30 (9) , 600-607
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Prognostic value of early response assessment using 18F-FDG PET/CT in chemotherapy-treated patients with non-small-cell lung cancerNuclear Medicine Communications, 2015
- Diagnosis of ovarian cancerBMJ, 2015
- An international assessment of ovarian cancer incidence and mortalityGynecologic Oncology, 2013
- The Role of 18F-FDG PET in Assessing Therapy Response in Cancer of the Cervix and OvariesJournal of Nuclear Medicine, 2009
- Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography—A prospective studyGynecologic Oncology, 2008
- Predictive and prognostic value of FDG-PETCancer Imaging, 2008
- Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literatureInternational Journal of Gynecological Cancer, 2007
- Incremental Benefits of FDG Positron Emission Tomography over CT Alone for the Preoperative Staging of Ovarian CancerAmerican Journal of Roentgenology, 2004
- Relapsed Ovarian Cancer: Challenges and Management Strategies for a Chronic DiseaseThe Oncologist, 2002
- Positive Emission Tomography for Evaluating a Complete Clinical Response in Patients with Ovarian or Peritoneal Carcinoma: Correlation with Second-Look LaparotomyGynecologic Oncology, 2001